Skip to content

PEPTIDE NEWS

News

Follow the headline.
Then follow the source.

Source-attributed news, kept separate from Atlas evidence and protocols. Dates are publication dates; this is a curated feed, not a real-time wire. Sources checked 2026-11-08.

120 Study. Compound tags come from names in each headline or summary, not from Atlas review.

YOUR NEXT RESEARCH THREAD

Choose a topic briefing.

Topic counts describe headlines, not research quality. Open a topic to narrow the feed.

16 headlinesSemaglutideOpen briefing 16 headlinesTirzepatideOpen briefing 14 headlinesGlutathioneOpen briefing 3 headlinesOxytocinOpen briefing 2 headlinesKisspeptinOpen briefing 2 headlinesKlothoOpen briefing

Search headlines or sources

Compound

November 2026

Study · 2026-11-05 · Europe PMC

Urolithin A Stabilizes CPT1A to Promote HUWE1-Associated NCOA4 Degradation and Alleviate Glucocorticoid-Induced Osteonecrosis of the Femoral Head. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-05 · Europe PMC

The Influence of GLP-1 Receptor Agonists on the Outcomes and Tolerability of Colorectal Cancer Therapies. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-05 · Europe PMC

NSAID initiation and risk for gastrointestinal bleeding in patients receiving GLP-1 receptor agonists: A retrospective cohort study. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-05 · Europe PMC

GLP-1 Receptor Agonists Across the Coronary Disease Continuum in Type 2 Diabetes: A Systematic Review of Ischemic Events, Revascularization, and Stent Healing ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-05 · Europe PMC

Direct cardiac or systemic? Reexamining the cardiovascular mechanisms of SGLT2 inhibitors and GLP-1 receptor agonists. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-04 · Europe PMC

Monosynaptic GABAergic Projections from a Subset of Suprachiasmatic Nucleus Neuromedin S Neurons Suppress Preoptic Area Kisspeptin Neuron Firing in Female Mice. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-04 · Europe PMC

Incidence of Barrett's Esophagus Among Adults With Obesity Treated with GLP-1 Receptor Agonists. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-04 · Europe PMC

Falls, fractures, lean mass and age with GLP-1receptor agonists and tirzepatide: meta-analysis of 162 placebo-controlled trials andage-subgroup data for adults aged 75 years orolder ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-04 · Europe PMC

Semaglutide and Kidney Outcomes in Type 2 Diabetes Patients at Low to Moderate Kidney Risk: A Retrospective Active-Comparator Cohort Study ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-04 · Europe PMC

Glucagon-like peptide-1 receptor agonists in diabetic patients with heart failure with reduced ejection fraction - real world outcomes ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-04 · Europe PMC

The molecular basis of GshT substrate binding reveals how Streptococcus pneumoniae acquires the antioxidant glutathione. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-04 · Europe PMC

Tirzepatide for the treatment of obstructive sleep apnea: from apnea-hypopnea index reduction to cardiometabolic risk mitigation-a narrative review. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-04 · Europe PMC

GLP-1 and GIP receptor agonism does not directly drive skeletal muscle atrophy or impair myogenesis in primary human myotubes. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-04 · Europe PMC

Investigating GLP-1 sourcing preferences on social media and motivations for use: Survey with choice-based conjoint (CBC) exercise. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-04 · Europe PMC

Availability of age-stratified evidence for GLP1 receptor agonists and SGLT2 inhibitors: an analysis of European public assessment reports with a focus on older patients ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-03 · Europe PMC

Effect of repeated oxytocin administration on ovulatory follicle dynamics, luteal function, and prostaglandin secretion in cyclic Nili-Ravi buffaloes. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-03 · Europe PMC

GLP-1 Receptor Agonists in Metabolic Dysfunction-Associated Steatotic Liver Disease and Cardiovascular Disease: A Review. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-03 · Europe PMC

Digital Augmentation of Glucagon-Like Peptide-1 for Obesity Management: Retrospective Study. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-03 · Europe PMC

Disrupted glutathione homeostasis contributes to copper-induced oxidative stress and DNA damage in human granulosa cells. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-03 · Europe PMC

The Future Burden of Type 2 Diabetes and the Role of Glycaemic Control and GLP1-RAs. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-03 · Europe PMC

Beyond Weight Loss: A Scoping Review and Thematic Analysis of GLP-1 Receptor Agonists Across the Neurosurgical Landscape. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-03 · Europe PMC

Assessment of preoperative gastric content with ultrasound in patients taking GLP-1 receptor agonists: an observational, multicenter, cross-sectional study. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-03 · Europe PMC

Recommendations for the use of semaglutide for the management of obesity in children and young people in England: expert consensus statements using a Delphi-like process. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-03 · Europe PMC

Changes in Metabolic and Blood Pressure Outcomes With Semaglutide Across Chronic Kidney Disease Stages: A Post Hoc Analysis of the FLOW Trial. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-03 · Europe PMC

Semaglutide, Tirzepatide and Clinically Recorded Alcohol-Related Outcomes in Type 2 Diabetes: A Target Trial Emulation. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Tirzepatide Semaglutide

Study · 2026-11-03 · Europe PMC

Bleeding and Thromboembolic Outcomes Following GLP-1 Receptor Agonist Initiation in Patients With Type 2 Diabetes and Atrial Fibrillation Receiving Direct Oral Anticoagulants: A Target Trial Emulation ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-03 · Europe PMC

Beyond the Scale: Psychological and Behavioural Considerations Following GLP-1 Receptor Agonist Treatment Discontinuation. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-03 · Europe PMC

Efficacy and Safety of Bilpatide, a Bi-weekly GIP/GLP-1 Receptor Agonist, in Chinese Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-03 · Europe PMC

GLP-1 Receptor agonist use and attempted access in individuals with and without lifetime eating disorders: The role of diagnostic history, BMI, and medication motivation ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-03 · Europe PMC

Apolipoprotein E4 Exacerbates Aβ Oligomer-Induced Synaptotoxicity through Promoting Autophagic Degradation of Glutathione Peroxidase 4 ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-03 · Europe PMC

Cardiometabolic benefits of glucagon-like peptide-1 receptor agonists and dual agonists: from obesity and diabetes to heart failure with preserved ejection fraction. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-03 · Europe PMC

Use of GLP-1 RAs before or during pregnancy was not linked to maternal pregnancy complications. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-03 · Europe PMC

In T2D, combined SGLT2i + GLP-1 RA vs. either alone does not reduce MACE or renal outcomes. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-03 · Europe PMC

Bariatric Surgery as a Rescue Strategy After Semaglutide or Tirzepatide. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Tirzepatide Semaglutide

Study · 2026-11-02 · Europe PMC

Oxytocin Signaling Bidirectionally Modulates Serotonergic and Dopaminergic Neurons in the Dorsal Raphe Nucleus. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-02 · Europe PMC

Semaglutide and Cardiovascular Death: a Systematic Review and Meta-Analysis Cardioprotective Efficacy of Semaglutide. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-02 · Europe PMC

GLP-1 Receptor Agonists and Obesity-Related Cancer by Diabetes Severity. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-02 · Europe PMC

Glucagon-Like Peptide-1 Receptor Agonists and the Eye: Ocular Safety, Retinal Outcomes, and Clinical Implications. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-02 · Europe PMC

GDF15 modifies NAD+ salvage pathway and dampens immune response in mitochondrial disease ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-02 · Europe PMC

Real-World Comparison of Cardiorenal Outcomes With SGLT-2 Inhibitors Versus GLP-1 Receptor Agonists in Type 2 Diabetes. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-02 · Europe PMC

GLP-1 receptor agonists: heart failure medications that also produce weight loss? ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-02 · Europe PMC

Evolutionary perspectives on GLP-1 receptor agonists and the modern obesity, sedentary behaviour, and loneliness epidemics. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-02 · Europe PMC

GLP-1 Enhances IL-27 Production in RAW264.7 Macrophages Via Activation of the PI3K/AKT Pathway. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-02 · Europe PMC

GLP-1 Receptor Agonists Versus Empagliflozin or Dapagliflozin in the MASLD-Heart Failure Phenotype: An Exploratory Propensity-Matched Cohort Study. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-02 · Europe PMC

Tirzepatide-associated severe euvolemic hyponatremia with syndrome of inappropriate antidiuretic hormone secretion-compatible biochemical features. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-02 · Europe PMC

Thiolate addition to withaferin A: a GFN2-xTB and DFT study of site-selective glutathione conjugation ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-02 · Europe PMC

Placental Klotho responses to supervised prenatal exercise: findings from the PLACENTRAINING study ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-02 · Europe PMC

The effect of glucagon-like peptide-1 receptor agonists on bone metabolism: A systematic review and meta-analysis of randomized placebo-controlled trials of predominantly first-generation agents. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-02 · Europe PMC

Renal Effects of Dual GLP-1/Glucagon Receptor Agonism: How Should We SYNCHRONIZE With Emerging Evidence in Type 2 Diabetes and Obesity? ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-02 · Europe PMC

Semaglutide or Tirzepatide Added to Psychological Support in Binge Eating Disorder With Overweight or Obesity: The LEAP-BED Prospective Pilot Study. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Tirzepatide Semaglutide

Study · 2026-11-01 · Europe PMC

Effects of glucagon-like peptide-1 analogs on prolactin levels: A secondary analysis of a randomized, double-blind, placebo-controlled crossover trial. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-01 · Europe PMC

Ionic Liquid Vesicle-Confined Curcumin: Tunable Excited-State Dynamics and Interaction with Glutathione-Capped Nanoclusters. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-01 · Europe PMC

[In the comparison of medications available in the USA for weight management tirzepatide shows the greatest effectiveness.] ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-01 · Europe PMC

Oral Semaglutide and the Kidney: Promise, Limitations, and the Road Ahead. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-01 · Europe PMC

Oral calcium carbonate as an adjunct to oxytocin for labor induction: considerations for a definitive trial. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-01 · Europe PMC

Semaglutide and Panic Attacks: Active-Comparator Disproportionality Analysis, Temporal Assessment of Notoriety Bias and Evidence Triangulation in Post-Marketing Pharmacovigilance. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-01 · Europe PMC

Unapproved GLP-1 Drugs Retatrutide and Zenagamtide Sold Online Are No Bargain. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-01 · Europe PMC

Liraglutide and Semaglutide Induce Nitric Oxide-Dependent Contraction of Larger and Relaxation of Smaller Porcine Retinal Resistance Vessels Ex Vivo. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-01 · Europe PMC

Biliary Events and GLP-1 Receptor Agonist Therapy in Adolescents and Young Adults. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-01 · Europe PMC

Development of an albumin-binding domain-fused GLP-1 analog: Structural insights, receptor activation, and functional characterization. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-01 · Europe PMC

Association of GLP-1 receptor agonist and SGLT2 inhibitor use with outcomes in patients with type 2 diabetes undergoing pacemaker implantation. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-01 · Europe PMC

GLP-1 Receptor Agonist Effects on Food-Related Cognition: A Cognitive Neuroscience Framework. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-01 · Europe PMC

Glutathione-Responsive Nano-Prodrug Mediates Synergistic Photothermal Chemotherapy for Tumor Inhibition. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-01 · Europe PMC

PET Imaging of Dual GLP-1R and GIPR Targeting with [18F]AlF-NOTA-Asp2-Tirzepatide. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-01 · Europe PMC

CagriSema 2.4/2.4 mg versus CagriSema 1.0/1.0 mg in adults with type 2 diabetes: a dose-comparison systematic review and meta-analysis of randomized controlled trials ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-01 · Europe PMC

Tirzepatide Initiation in Lithium-Treated Bipolar Disorder: Renal Biomarker Trajectories and Lithium Safety Signals Over 12 Months in a Real-World Cohort. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-01 · Europe PMC

Hyping Bariatric Surgery Research in the Glucagon-Like Peptide-1 Era ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-01 · Europe PMC

GLP-1 Receptor Agonists and Cardiorenal Outcomes in Non-Obese, Non- Diabetic MASLD: A Propensity Score-Matched Study ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-01 · Europe PMC

Non-ST Elevation Myocardial Infarction Following Significant Weight Loss During Tirzepatide Therapy: A Case Report ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-01 · Europe PMC

Comparative Short-term Risk of Severe Gastrointestinal Events Associated With Opioid Type Among Patients Receiving Glucagon-Like Peptide 1 Receptor Agonists. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-01 · Europe PMC

Microsomal glutathione S-transferase 2high polymorphonuclear neutrophils mediate neutrophil extracellular traps and drive pericyte-to-myofibroblast transition in rheumatoid arthritis-associated inters ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-01 · Europe PMC

Topology-driven activation of the glucagon-like peptide-1 receptor promotes adipose tissue browning. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-01 · Europe PMC

The Gain-of-Function GLP1R R131Q Variant Preserves β-Cell Function and Enhances Response to GLP-1 Receptor Agonists. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-01 · Europe PMC

State-Level Variation in GLP-1 Receptor Agonist Use Among Medicaid Beneficiaries Without Diabetes by State Obesity Coverage Policy. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-01 · Europe PMC

Global Landscape and Thematic Evolution of Selective GLP-1 Receptor Agonists and GLP-1-Based Multi-Receptor Agonists in Type 2 Diabetes Mellitus: A Bibliometric Analysis. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-01 · Europe PMC

Klotho Deficiency Impairs Distal Potassium Homeostasis Through mTORC1-Dependent Suppression of ROMK. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-01 · Europe PMC

Probing the many benefits of GLP-1 receptor agonists. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-01 · Europe PMC

GLP-1 receptor agonist initiation and risk of psychiatric hospitalisation and emergency department presentation in adults with schizophrenia and type 2 diabetes in the USA: an observational cohort stu ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-01 · Europe PMC

Evidence on Glutathione and Boosters for Prevention of Chemotherapy-Induced Neuropathy: A Systematic Review and Network Meta-Analysis. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-01 · Europe PMC

Toward Precision Prescribing of GLP-1 Receptor Agonists for Glucose Lowering. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-01 · Europe PMC

A Cilia-Centered Nicotinamide Adenine Dinucleotide (NAD+) Signaling Network Regulates Hypothalamic Lysosomal Homeostasis and Metabolic Aging. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-01 · Europe PMC

Arcuate kisspeptin neurons display two types of calcium events: Regulation by sex, gonads, and senktide. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-11-01 · Europe PMC

Urolithin A Attenuates Noise-induced Hearing Loss and Is Associated With Increased Cochlear Mitophagy Markers. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

October 2026

Study · 2026-10-31 · Europe PMC

Trends in use of glucagon-like peptide-1 receptor agonists in obese patients with endometrial cancer. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-10-31 · Europe PMC

Efficacy and safety of semaglutide versus placebo in adults with overweight or obesity without diabetes: updated meta-analysis of randomized trials. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-10-31 · Europe PMC

Baseline monocyte GIP receptor mRNA expression is associated with reductions in body weight and FIB-4 index after switching to tirzepatide in patients with type 2 diabetes. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-10-31 · Europe PMC

Baseline depressive-symptom severity and divergent psychological trajectories during GIP and/or GLP-1 receptor agonist therapy: a prospective ecological momentary assessment study. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-10-31 · Europe PMC

Glycemic control and weight loss benefits of fixed-ratio combinations of basal insulins and GLP1 receptor agonists in type 2 diabetes: A systematic review and network meta-analysis. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-10-31 · Europe PMC

A test of the Tripartite Influence Model in the context of GLP-1 medication consideration among women in the United Kingdom. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-10-31 · Europe PMC

Association of GLP-1 receptor agonist therapy with cardiovascular outcomes in patients with MASLD: A translational study. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-10-31 · Europe PMC

Loss of GIPR in glutamatergic neurons does not impair acceleration of GLP-1-induced weight loss by GIPR antagonism. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-10-31 · Europe PMC

CRISPR/Cas9-Mediated Mutagenesis of Two Alleles Encoding a Glutathione S-Transferase Confirms Their Identity as Fhb7 Conferring Fusarium Head Blight Resistance in Wheat. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-10-31 · Europe PMC

Pregnancy and perinatal outcomes following exposure to GLP-1 and dual GLP-1/GIP receptor agonists: a time-window-stratified systematic review and meta-analysis ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-10-31 · Europe PMC

Beyond glycemic control: cardiovascular and kidney benefits of GLP-1 receptor agonists and the dual GIP/GLP-1 receptor agonist tirzepatide: a narrative review ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-10-31 · Europe PMC

Glutathione-functionalized PVC for hydrogen-bonding assisted fluorescein adsorption and radical scavenging ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-10-30 · Europe PMC

Cardiovascular and Cerebrovascular Outcomes Risk Reduction Associated With Semaglutide vs Tirzepatide: Methodological Concerns. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Tirzepatide Semaglutide

Study · 2026-10-30 · Europe PMC

Glutathione-functionalized PVC for hydrogen-bonding assisted fluorescein adsorption and radical scavenging. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-10-30 · Europe PMC

Oxidized Glutathione-Regulated Plant Cell Death of Chinese Cabbage Leaves Against Adapted and Nonadapted Xanthomonas Species. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-10-30 · Europe PMC

Analysis Asks: Are GLP-1 Drugs Safe in People With Frailty? ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-10-30 · Europe PMC

Survey Suggests GLP-1 Drugs May Curb Alcohol Use for Many Patients. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-10-30 · Europe PMC

Oral small-molecule GLP-1 receptor agonist for obesity in people from Japan. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-10-30 · Europe PMC

The metabolic-brain axis: GLP-1 signaling, insulin resistance, and obesity pharmacotherapy in neurodegeneration. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-10-30 · Europe PMC

From metabolic therapy to addiction care: a clinical pharmacology roadmap for GLP-1 receptor agonists in substance use disorders. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-10-30 · Europe PMC

Metabolic, hormonal, and reproductive effects of GLP-1 receptor agonizts in hyperandrogenic insulin-resistant women: a systematic review. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-10-30 · Europe PMC

Glucagon-Like Peptide-1 Receptor Agonists in Obese Heart Failure With Preserved Ejection Fraction. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-10-30 · Europe PMC

Glucagon-Like Peptide-1 Analog-Type Amyloidosis: A Case Report and Review of the Literature. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-10-30 · Europe PMC

Combined time-restricted feeding and resistance training enhance tirzepatide-induced improvements in adiposity and whole-body insulin sensitivity in female mice. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-10-30 · Europe PMC

Exploring the impact of GLP-1 analogues and DPP-4 inhibitors on cognitive decline in elderly patients with type 2 diabetes: a competing risks analysis from a real-world cohort ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-10-29 · Europe PMC

Switching between semaglutide and tirzepatide in obesity Management: an expert-consensus framework for approximate clinical Efficacy-matched switching doses. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Tirzepatide Semaglutide

Study · 2026-10-29 · Europe PMC

Comparative adverse-event reporting patterns of semaglutide and tirzepatide: a disproportionality analysis of FAERS. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Tirzepatide Semaglutide

Study · 2026-10-29 · Europe PMC

Early Treatment Trajectory and Long-Term Persistence to Semaglutide for Obesity: A Population-Based Cohort Study. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-10-29 · Europe PMC

Do Preoperative Glucagon-Like Peptide-1 Receptor Agonists Influence Lumbar Fusion Outcomes? A Systematic Review and Meta-Analysis. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-10-29 · Europe PMC

Semaglutide versus other GLP-1 RAs and cardiovascular risk in obesity-related cancer survivors. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-10-29 · Europe PMC

GLP-1 Receptor Agonists Decrease the Rate of Rupture, Cardiac Events, and Death in Patients with Abdominal Aortic Aneurysms. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-10-29 · Europe PMC

Digital Food Purchase Signatures and Their Response to GLP-1-Based Treatment in People With Obesity. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-10-29 · Europe PMC

The rapid growth in GLP-1 use could reshape the U.S. agricultural landscape ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-10-29 · Europe PMC

Sex differences in glucagon-like peptide-1 signalling and the implications for Alzheimer's disease: A narrative review. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-10-28 · Europe PMC

Glutaminolysis Shapes Cardiac Resilience to Stress via Mitochondrial Glutathione. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-10-28 · Europe PMC

The Effects of Blueberry Consumption on Cerebral Blood Flow and Brain Glutathione Levels in Older Adults: A Double-Blind Randomized, Placebo-Controlled Trial. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

Study · 2026-10-28 · Europe PMC

VIP-Mediated Syndromes: Contrasting Presentations and Multidisciplinary Management of Two Rare Neuroendocrine Tumors. ↗

Indexed research record from Europe PMC. Headline and link only; the Atlas has not reviewed it and it is not Atlas evidence.

A news item is not an Atlas evidence record and does not change any evidence class. Not medical advice.